Clinical Trial Update: A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety, pharmacokinetics, and pharmacodynamics of BMS-962212 in healthy subjects, with thrombosis as the condition …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• BMS-962212

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Thrombosis | Phase 1 | Status: COMPLETED